EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Oral–Gut–Brain Axis: From Periodontal Dysbiosis to Neuroinflammation—Mechanistic Pathways, Salivary and Intestinal Biomarkers, and Therapeutic Targets: A Narrative Review

Caterina Nela Dumitru, Alina Oana Dumitru iD, Gabriel Valeriu Popa, Teodora Marcu, Maria Ursu iD, Aurel Nechita, Nicoleta Madalina Matei

Dentistry Journal · 11.05.2026 · 14 (5) · 289

DOI: 10.3390/dj14050289 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Dentistry Journal, online erschienen am 11.05.2026. Verfasst von Caterina Nela Dumitru und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre in the Medical-Pharmaceutical Field, Faculty of Medicine and Pharmacy, "Dunărea de Jos" University of Galați, 35 Al. I. Cuza Street, …. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dunarea de Jos University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Periodontitis affects approximately 7–11% of the global adult population in its severe forms and has been epidemiologically associated with cardiovascular, cardiometabolic, and neurodegenerative diseases. Low-grade chronic inflammation represents the unifying mechanism; however, an integrative framework connecting the oral cavity, the gut, and the brain into a single mechanistic continuum is lacking.

Objective

This narrative review, conducted with structured (but non-systematic) elements and PRISMA-2020 style reporting used solely as a transparency tool, synthesizes current evidence on the oral–gut–brain axis. A comprehensive literature search was conducted in PubMed/MEDLINE, Scopus, Web of Science, and Google Scholar (2000–March 2026), yielding 159 included studies after structured screening and eligibility assessment. The review focuses on: the molecular mechanisms by which periodontal dysbiosis may disrupt intestinal homeostasis and contribute to neuroinflammation; the role of salivary and intestinal biomarkers as monitoring tools for the entire axis; and emerging pharmacological opportunities targeting this tripartite pathway.

Results

Periodontal pathogens, particularly Porphyromonas gingivalis (P. gingivalis) and Fusobacterium nucleatum, have been detected ectopically in the gut and are associated with reduced tight junction protein expression and altered Firmicutes/Bacteroidetes ratios in preclinical and observational studies. These perturbations have been associated with increased blood–brain barrier (BBB) permeability, microglial activation, and amyloid-beta (Aβ) accumulation, although causal directionality in humans remains to be established. Salivary biomarkers (MMP-8, IL-1β, IL-6, BDNF) and intestinal biomarkers (short-chain fatty acids, calprotectin) reflect systemic inflammatory burden and offer potential for non-invasive screening.

Conclusions

The oral–gut–brain axis provides a plausible unifying framework for understanding comorbidity among periodontal, cardiometabolic, and neurodegenerative diseases; however, current evidence is predominantly associative, and mechanistic extrapolation from preclinical models requires validation in longitudinal human studies. Salivary biomarkers may serve as candidate first-line tools for systemic risk assessment, and pharmacological interventions targeting this axis represent promising investigational directions warranting further clinical evaluation.

Schlagwörter

Stichwörter der Autor:innen

Porphyromonas gingivalisblood–brain barrierdysbiosislow-grade chronic inflammationmicroglial activationneuroinflammationoral–gut–brain axisperiodontitissalivary biomarkersshort-chain fatty acids

Autor:innen und Institutionen

  • Research Centre in the Medical-Pharmaceutical Field, Faculty of Medicine and Pharmacy, "Dunărea de Jos" University of Galați, 35 Al. I. Cuza Street, Galați County, 800010 Galați, Romania.
  • "Sf. Cuvioasa Parascheva" Clinical Hospital of Infectious Diseases, Galați County, 800179 Galați, Romania.
  • Pharmaceutic Department, Faculty of Medicine and Pharmacy, "Dunărea de Jos" University of Galati, 800201 Galati, Romania.
  • Faculty of Medicine and Pharmacy, "Dunărea de Jos" University of Galați, 35 Al. I. Cuza Street, Galați County, 800010 Galați, Romania.
  • Dental-Medicine Department, Faculty of Medicine and Pharmacy, "Dunărea de Jos" University of Galati, 800201 Galati, Romania.
  • "Sf. Ioan" Clinical Emergency Pediatric Hospital in Galati, 800487 Galati, Romania.

ORCID-Profile: Alina Oana Dumitru, Maria Ursu

Förderung

  • Dunarea de Jos University

Zitieren

APA

Dumitru, C. N., Dumitru, A. O., Popa, G. V., Marcu, T., Ursu, M., Nechita, A., & Matei, N. M. (2026). The Oral–Gut–Brain Axis: From Periodontal Dysbiosis to Neuroinflammation—Mechanistic Pathways, Salivary and Intestinal Biomarkers, and Therapeutic Targets: A Narrative Review. Dentistry Journal, 14(5), 289. https://doi.org/10.3390/dj14050289

Vancouver

Dumitru CN, Dumitru AO, Popa GV, Marcu T, Ursu M, Nechita A, et al. The Oral–Gut–Brain Axis: From Periodontal Dysbiosis to Neuroinflammation—Mechanistic Pathways, Salivary and Intestinal Biomarkers, and Therapeutic Targets: A Narrative Review. Dentistry Journal. 2026;14(5):289. doi:10.3390/dj14050289

BibTeX
@article{Dumitru2026,
  author = {Dumitru, Caterina Nela and Dumitru, Alina Oana and Popa, Gabriel Valeriu and Marcu, Teodora and Ursu, Maria and Nechita, Aurel and Matei, Nicoleta Madalina},
  title = {The Oral–Gut–Brain Axis: From Periodontal Dysbiosis to Neuroinflammation—Mechanistic Pathways, Salivary and Intestinal Biomarkers, and Therapeutic Targets: A Narrative Review},
  journal = {Dentistry Journal},
  year = {2026},
  volume = {14},
  number = {5},
  pages = {289},
  doi = {10.3390/dj14050289}
}
Kostenlos starten →